Prime Medicine (PRME)
3.21
0.00 (0.00%)
Upcoming Events
Latest Headlines
Prime Medicine (PRME) Reiterated at Market Outperform by Citizens
October 6, 2026 5:35 AM - StreetInsider
Prime Medicine doses first patient in Wilson disease gene editing trial
October 5, 2026 8:00 AM - StreetInsider
Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
October 5, 2026 8:00 AM - StreetInsider
Prime Drink Group Announces Filing of Annual and Interim Financial Statements and Anticipated CTO Revocation
September 30, 2026 10:54 AM - Globe NewsWire
Prime Medicine (PRME) Reiterated at Market Outperform by Citizens - Still a Leader in Prime Editing
September 28, 2026 4:33 AM - StreetInsider
Prime Medicine (PRME) Reiterated at Market Outperform by Citizens as PM647 Application Cleared
September 25, 2026 4:14 AM - StreetInsider
Prime Drink Group Provides Bi-Weekly MCTO Status Report
September 24, 2026 5:30 PM - Globe NewsWire
Prime Medicine stock surges on FDA IND clearance
September 24, 2026 4:38 PM - StreetInsider
FDA clears Prime Medicine's IND for AATD gene editing therapy
September 24, 2026 4:01 PM - StreetInsider
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency
September 24, 2026 4:01 PM - StreetInsider
Prime Drink Group Finalizes Settlement With Creditors
September 21, 2026 7:30 AM - Globe NewsWire
Prime Drink Group Provides Bi-Weekly MCTO Status Report
September 10, 2026 5:30 PM - Globe NewsWire
Prime Drink Group closes first tranche of private placement at $1.35M
September 10, 2026 7:30 AM - StreetInsider
Prime Drink Group Announces First Closing of Private Placement
September 10, 2026 7:30 AM - Globe NewsWire
Prime Medicine to Participate in Upcoming Investor Conferences
September 3, 2026 8:00 AM - StreetInsider
Prime Drink Group Provides Bi-Weekly MCTO Status Report
August 27, 2026 5:30 PM - Globe NewsWire
Prime Drink Group signs LOI with Geloso for beverage brand expansion
August 27, 2026 7:31 AM - StreetInsider
Prime Drink Group Enters Into Strategic Partnership With Groupe Geloso to Accelerate the Expansion of Beach Day Every Day Across the Rest of Canada, the United States and Europe
August 27, 2026 7:31 AM - Globe NewsWire
BMO Capital Starts Prime Medicine (PRME) at Outperform
August 18, 2026 4:13 PM - StreetInsider
Prime Drink Group Provides Bi-Weekly MCTO Status Report
August 14, 2026 4:00 PM - Globe NewsWire
Prime Medicine, Inc. (PRME) Tops Q2 EPS by 12c
August 6, 2026 8:33 AM - StreetInsider
Form 10-Q Prime Medicine, Inc. For: Jun 30
August 6, 2026 8:04 AM - SEC Filing
Form 8-K Prime Medicine, Inc. For: Aug 06
August 6, 2026 8:02 AM - SEC Filing
Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 6, 2026 8:00 AM - StreetInsider
Prime Drink Group extends private placement, misses filing deadline
July 30, 2026 5:30 PM - StreetInsider
Prime Drink Group Extends Private Placement and Announces Delay in Filing Annual Financial Statements
July 30, 2026 5:30 PM - Globe NewsWire
Prime Medicine gets FDA clearance for Wilson disease gene therapy trial
July 23, 2026 4:05 PM - StreetInsider
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
July 23, 2026 4:05 PM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Prime Medicine (PRME)
July 10, 2026 6:52 AM - StreetInsider
TD Cowen on Prime Medicine (PRME): 'We continue to view PRME as undervalued for the platform’s potential'
July 8, 2026 12:30 PM - StreetInsider
BofA Securities Comments on Beam Therapeutics Inc (BEAM) Amid Selloff
July 8, 2026 11:32 AM - StreetInsider
Form 8-K Prime Medicine, Inc. For: Jul 06
July 8, 2026 8:02 AM - SEC Filing
Prime Medicine wins arbitration against Beam Therapeutics over PM647
July 8, 2026 8:00 AM - StreetInsider
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
July 8, 2026 8:00 AM - StreetInsider
Full Article List
